Access Quote by Chris Sununu

The higher cost of getting a generic drug approved by regulators means that many old medicines don't face competitors. It's only after substantial price…

— Scott Gottlieb

The regulatory approach of the Food and Drug Administration and the Patent and Trademark Office has driven up the costs of generic drugs.

— J. D. Vance

Competition is the best way to ensure prescription drugs are affordable.

— Amy Klobuchar

One of the biggest factors fueling the angst over drug prices in the U.S. is that some older medicines that should be sold cheaply…

— Scott Gottlieb

Drugs should be available for cheap prices for patients.

— Pinarayi Vijayan

The key to the generic-drug economic model is to keep entry prices low enough to attract multiple competitors.

— Scott Gottlieb

The value that the generic drug industry brings to the U.S. healthcare system is indisputable.

— Heather Bresch

I don't want to suggest that controlling pharmaceutical costs is the answer to what ails the U.S. health care system. It isn't.

— John Kitzhaber

One dirty tactic big pharmaceutical companies use is keeping drug prices artificially high through anti-competitive conduct, such as paying competitors millions of dollars to…

— Mike Braun

We should look for ways to expedite generic drug approvals, particularly for products that have a long history of being safe and effective.

— Amy Klobuchar

With the Health Impact Fund, the innovation is paid for separately, through publicly funded health impact rewards, and the product is sold at the…

— Thomas Pogge

Many countries which are no longer able to afford their public health systems, which have made certain promises within their countries to purchase from…

— Nirmala Sitharaman